Emcure Q3FY26 results show 20% YoY revenue growth and 48% rise in PAT, driven by strong domestic performance and robust international expansion.
Read MorePoviztra
Novo Nordisk India Partners with Emcure Pharma to Launch Poviztra for Weight Management
Novo Nordisk India partnership with Emcure Pharma launches Poviztra, expanding access to semaglutide-based weight management treatment in India.
Read More